|
Thu, 05/17/2012 - 05:21
Gary Bloomgren, M.D., and colleagues from... |
Wed, 05/16/2012 - 08:03
The highest increases have been in Orkney, which now has the highest recorded rate worldwide at 402 (95% CI 319 to 500) per 100 000 using the Poser criteria (probable/definite). A rise in prevalence was also seen in Aberdeen and the... |
|
Wed, 05/16/2012 - 06:17
|
Tue, 05/15/2012 - 04:58
|
|
Tue, 05/15/2012 - 04:41
|
Mon, 05/14/2012 - 12:26
A clinical study of 30 adult patients with multiple sclerosis (MS) has shown that smoked cannabis may be an effective treatment for spasticity – a common and disabling symptom of this neurological disease. |
|
Mon, 05/14/2012 - 10:08
-- The new Avonex PEN (Avonex 30mcg/0.5mL solution for injection) is the first intramuscular (IM) autoinjector for chronic use, designed to enhance the self-injection process for patients receiving... |
Mon, 05/14/2012 - 05:45
The union said evidence from its members showed cuts to councils and hospitals were over-burdening nurses in the community. The research was released as nurses gather in Harrogate for their annual conference which will be addressed by the Health Secretary Andrew Lansley. Ministers have said reforms to the... |
|
Fri, 05/11/2012 - 10:35
An international meeting was convened to determine how to improve clinical measures so that MS progression can be better tracked, especially during clinical trials of experimental... |
Fri, 05/11/2012 - 08:25
Aged just 26, Mr Scott was diagnosed with the neurological condition, which can leave sufferers fatigued and facing problems with their walking and vision, in 2007. The prospect of facing a life stuck in a wheelchair left him severely depressed and missing the great outdoors. Now, however, with the help... |
Multiple sclerosis patients taking natalizumab are at higher risk of developing progressive multifocal leukoencephalopathy (PML) if they are positive for the anti-JC virus antibodies, have been treated with immunosuppressants, and have been treated with natalizumab for longer periods, according to a study published in the May 17 issue of the New England Journal of Medicine.
Summary: A new epidemiological study from the UK, examining prevalence of MS in northern Scotland, shows a rise in prevalence of the disease over the past 30 years.
Abstract (provisional)
As their European counterparts did last month, the FDA has recommended continued use of the Gilenya multiple sclerosis pill sold by Novartis, but did say the drug should carry stronger warnings about heart risks and that some patients should undergo increased monitoring. The move was largely expected after the European Medicines Agency issued a similar alert, despite arguments by a non-profit safety watchdog that further restrictions...
Smoking marijuana can relieve muscle tightness, spasticity (contractions) and pain often experienced by those with multiple sclerosis, says research out of the University of California, San Diego School of Medicine.
Biogen Idec announced that two new dosing innovations designed to help patients receiving once-a-week Avonex (interferon beta-1a) for relapsing forms of multiple sclerosis (MS) are now available in U.S. pharmacies:
Health services in the community are reaching breaking point in the UK, the Royal College of Nursing is claiming.
Disease progression, or gradual worsening, experienced by people who have multiple sclerosis usually occurs over many years, and it is difficult to track with the standard clinical measurement scales used by doctors to assess disease activity. 
Brave Graeme Scott is set to tackle some of the UK’s toughest mountains despite having multiple sclerosis.